GLP-1 receptor agonisms have been shown to affect different mechanisms of the secondary injury, not only in TBI, but also other conditions that share the same pathophysiological processes, notable examples being cerebral ischemia (CI), epilepsy, and various neurodegenerative disorders. This evidence concerns the gene GLP1R and brain ischemia.